Shanghai Eliansy Industry Group Corporation Limited Stocks

CN¥ 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

CN¥ 43.48M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shanghai Eliansy Industry Group Corporation Limited, together with its subsidiaries, engages in printing and medical services business in China and internationally. It offers green printing services; and trades in papers. The company also offers medical service training system; offers Chinese medicines; supplies pharmaceutical products; operates an Internet hospital specializing in chronic disease and cancer rehabilitation; operates a medical health industrial park; and real estate construction business, which include urban nursing home projects. It also invests in biomedicine, medical equipment, and health fields; information technology and artificial intelligence fields; and new materials, energy savings, and environment protection fields. The company was formerly known as Shanghai Jielong Industry Group Corporation Limited. Shanghai Eliansy Industry Group Corporation Limited is based in Shanghai, China.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks